is-1

1

1

1

1

1

1

1

1

1

1

1

Company

Clinical stage Dermatology company with a NCE which completed a large Phase 2b CT for Acne and Phase 1 for Psoriasis, and NCEs directed against different targets in Lead Identification phase.

Business
Model

Internal clinical, nonclinical, CMC, IP, regulatory expertise,
that enables NograDerm to develop Investigational Medicinal Products from target identification up to MAA/NDA.
Interaction with Academies, Consultants and KOLs for target identification, design of NCEs, nonclinical PoC studies.
Activities outsourced to CMOs and CROs, closely managed and monitored by NograDerm.